Digesting recent findings: gut alpha-synuclein, microbiome changes in Parkinson's disease

Area of Science:

• Neuroscience
• Gastroenterology
• Microbiology

Background:

• Parkinson's disease (PD) is characterized by alpha-synuclein (αSyn) aggregation and dopamine neuron loss.
• The enteric nervous system (ENS) is increasingly implicated in PD pathogenesis.
• Gut microbiome alterations are frequently observed in PD patients, but their role remains debated.

Purpose of the Study:

• To review the potential roles of αSyn and microbiome changes in the gastrointestinal (GI) system in PD.
• To explore the interaction between αSyn and the gut microbiome in PD development and symptoms.

Main Methods:

• Literature review of studies on αSyn, ENS, gut microbiome, and PD.
• Analysis of proposed mechanisms for gut-originated PD.
• Synthesis of current evidence on the interplay between gut factors and PD.

Main Results:

• Evidence suggests αSyn aggregation in the ENS may precede brain pathology and motor symptoms.
• Gut microbiome dysbiosis is associated with PD, but causality is unclear.
• A bidirectional relationship between αSyn pathology and microbiome changes is plausible.

Conclusions:

• The GI tract, through αSyn and microbiome alterations, is a potential origin and contributor to PD.
• Further research is needed to elucidate the precise mechanisms and interactions for therapeutic targeting.